Literature DB >> 10785851

Imaging guided biopsies of renal masses.

B R Herts1.   

Abstract

Percutaneous fine-needle aspiration biopsy can be used for the diagnosis of many abdominal masses. It is safe and accurate, and is often all that is necessary to determine treatment. Fine-needle aspiration biopsy is both accurate and cost-effective, comparing favorably with open surgical biopsy. The use of percutaneous biopsy for the diagnosis of renal masses is now more commonplace as urologists and radiologists become familiar with its indications, contraindications, accuracy and complications.

Mesh:

Year:  2000        PMID: 10785851     DOI: 10.1097/00042307-200003000-00010

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  6 in total

1.  Core needle biopsy clarify the histology of the small renal masses and may prevent overtreatment.

Authors:  N H Azawi; S A Tolouee; M Madsen; K D Berg; C Dahl; M Fode
Journal:  Int Urol Nephrol       Date:  2018-05-30       Impact factor: 2.370

2.  Mucosa-associated lymphoid tissue lymphoma arising from the kidney.

Authors:  Naoya Niwa; Nobuyuki Tanaka; Minoru Horinaga; Hiroshi Hongo; Yujiro Ito; Takuro Watanabe; Takeshi Masuda
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

Review 3.  [Biopsies of kidney lesions: when and how?]

Authors:  A H Schuster; N Reimann
Journal:  Radiologe       Date:  2018-10       Impact factor: 0.635

4.  The contemporary role of renal mass biopsy in the management of small renal tumors.

Authors:  Amy Lim; Brock O'Neil; Marta E Heilbrun; Christopher Dechet; William T Lowrance
Journal:  Front Oncol       Date:  2012-09-10       Impact factor: 6.244

Review 5.  Renal Tumor Biopsy Technique.

Authors:  Lei Zhang; Xue-Song Li; Li-Qun Zhou
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

6.  Indications for renal fine needle aspiration biopsy in the era of modern imaging modalities.

Authors:  Ema A Dragoescu; Lina Liu
Journal:  Cytojournal       Date:  2013-07-16       Impact factor: 2.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.